These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26506405)

  • 1. Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors.
    Wu S; Huang J; Gazzarrini S; He S; Chen L; Li J; Xing L; Li C; Chen L; Neochoritis CG; Liao GP; Zhou H; Dömling A; Moroni A; Wang W
    ChemMedChem; 2015 Nov; 10(11):1837-45. PubMed ID: 26506405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
    Musharrafieh R; Ma C; Wang J
    Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.
    Rey-Carrizo M; Gazzarrini S; Llabrés S; Frigolé-Vivas M; Juárez-Jiménez J; Font-Bardia M; Naesens L; Moroni A; Luque FJ; Vázquez S
    Eur J Med Chem; 2015; 96():318-29. PubMed ID: 25899336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalent copper complexes as influenza A M2 inhibitors.
    Gordon NA; McGuire KL; Wallentine SK; Mohl GA; Lynch JD; Harrison RG; Busath DD
    Antiviral Res; 2017 Nov; 147():100-106. PubMed ID: 29032206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.
    Yu Y; Tang Q; Xu Z; Li S; Jin M; Zhao Z; Dong C; Wu S; Zhou HB
    Eur J Med Chem; 2018 Nov; 159():206-216. PubMed ID: 30292897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
    Wang J; Ma C; Wang J; Jo H; Canturk B; Fiorin G; Pinto LH; Lamb RA; Klein ML; DeGrado WF
    J Med Chem; 2013 Apr; 56(7):2804-12. PubMed ID: 23437766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.
    Rey-Carrizo M; Barniol-Xicota M; Ma C; Frigolé-Vivas M; Torres E; Naesens L; Llabrés S; Juárez-Jiménez J; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2014 Jul; 57(13):5738-47. PubMed ID: 24941437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
    Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
    Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus.
    Dong J; Chen S; Li R; Cui W; Jiang H; Ling Y; Yang Z; Hu W
    Eur J Med Chem; 2016 Jan; 108():605-615. PubMed ID: 26722757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
    Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
    Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
    Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
    Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.
    Jacob A; Sood R; Chanu KhV; Bhatia S; Khandia R; Pateriya AK; Nagarajan S; Dimri U; Kulkarni DD
    Microb Pathog; 2016 Feb; 91():35-40. PubMed ID: 26639679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a new class of antiviral compounds: camphor imine derivatives.
    Sokolova AS; Yarovaya OI; Shernyukov AV; Gatilov YV; Razumova YV; Zarubaev VV; Tretiak TS; Pokrovsky AG; Kiselev OI; Salakhutdinov NF
    Eur J Med Chem; 2015 Nov; 105():263-73. PubMed ID: 26498572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategy for high throughput screening of anti-influenza virus M2 ion channel inhibitors.
    Li C; Long Y; Lin Z; Jie Y; Xiao Y; Yang L; Sun J; Ren Y; Chen L; Li Z
    Curr Pharm Des; 2013; 19(28):5146-55. PubMed ID: 23621591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
    Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
    Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.